Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 29.05 CNY -5.03% Market Closed
Market Cap: 15.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Qingdao Baheal Medical Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Qingdao Baheal Medical Inc
Gross Profit Peer Comparison

Comparables:
1099
601607
600998
C
600511
000963

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao Baheal Medical Inc
SZSE:301015
Gross Profit
ÂĄ2.3B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Sinopharm Group Co Ltd
HKEX:1099
Gross Profit
ÂĄ47.2B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
12%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Gross Profit
ÂĄ29.7B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Gross Profit
ÂĄ11.1B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
16%
C
China National Medicines Corp Ltd
SSE:600511
Gross Profit
ÂĄ3.8B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
16%
Huadong Medicine Co Ltd
SZSE:000963
Gross Profit
ÂĄ13.3B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
13%

See Also

What is Qingdao Baheal Medical Inc's Gross Profit?
Gross Profit
2.3B CNY

Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Gross Profit amounts to 2.3B CNY.

What is Qingdao Baheal Medical Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
14%

Over the last year, the Gross Profit growth was 9%. The average annual Gross Profit growth rates for Qingdao Baheal Medical Inc have been 16% over the past three years , 14% over the past five years .

Back to Top